Dr. Mohammad Mobayed, MD

  • Troy, MI
  • Hematologist and oncologist
NPI1114134632PAC ID9739359688
Medicare services, 2024
26,295
Medicare patients, 2024
437
Part D claims, 2024
808
Publications
1
MIPS score, 2024
75
Practice address
44201 Dequindre Road, Troy, MI 48085
Practice phone
Call (248) 964-8800
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Corewell Health Beaumont Troy Hospital

Hospital · Troy, Michigan

See all 7 affiliations

Find Dr. Mobayed's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mohammad Mobayed is a hematologist and oncologist in Troy, Michigan

Dr. Mobayed practices at Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health.

Dr. Mobayed's NPI, 1114134632, was assigned on May 16, 2007. Dr. Mobayed holds Michigan license 4301085805.

NPI and contact details
Medicare PAC ID
9739359688
NPI enumeration date
May 16, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(248) 964-8800
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
48
Medical school graduation
2004

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mohammad Mobayed practices at Corewell Health Beaumont Troy Hospital in Troy, Michigan

Dr. Mobayed's primary practice is Corewell Health Beaumont Troy Hospital, at 44201 Dequindre Road, Troy, MI 48085 in Oakland County. The practice phone is (248) 964-8800.

Source: Dmand AI Affiliation Data

Dr. Mohammad Mobayed is affiliated with 6 sites of care and 1 medical group

Dr. Mobayed's primary practice is Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health. Dr. Mobayed is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Oakland Macomb Cancer Specialists. Dmand AI also links Dr. Mobayed to 3 more hospitals and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Mobayed

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mohammad Mobayed's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mobayed practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Corewell Health Beaumont Troy HospitalAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Mobayed practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Corewell Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mohammad Mobayed is one of 298 hematologists and oncologists in Michigan

Hematology and oncology is Dr. Mobayed's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Mobayed's licenses on file in 2 states: Michigan and Texas.

Specialties and state licenses

  • Hematology and oncology, MichiganPrimaryLicense 4301085805 · taxonomy 207RH0003X
  • Texas licenseLicense P6682

Hematologists and oncologists near Dr. Mobayed

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mohammad Mobayed billed Medicare for 26,295 services in 2024

CMS data shows 26,295 Medicare services from Dr. Mobayed across 35 procedure codes in 2024, for 437 Medicare patients. Medicare paid $399,505 for them.

Medicare services, 202426,295
Medicare patients437
Paid by Medicare$399,505
Procedure codes35

Dr. Mobayed's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 1,6222024: 21,8991250%
Office and hospital visits
2023: 1,1532024: 2,03576%
Tests and treatments
2023: 1562024: 1,529880%
Other services
2023: 252024: 7182772%
Lab and pathology
2023: 02024: 95
Surgery
2023: 192024: 19No change

Where Dr. Mobayed's Medicare services took place, 2024

  • In an office25,24996%
  • In a facility1,0464%

Dr. Mobayed compared with the Michigan median for hematologists and oncologists, 2024

  • Dr. Mobayed
  • Michigan median
Medicare services
26,295vs 61942.5 times
Medicare patients
437vs 22892% above
Part D claims
554vs 37847% above

Medians across 291 hematologists and oncologists in Michigan with Dmand AI profiles that report each measure.

Dr. Mobayed's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mobayed

Need commercial claims for Dr. Mobayed?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mobayed and other hematologists and oncologists in Michigan.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mohammad Mobayed treated 437 Medicare patients in 2024, average age 76

CMS counts 437 Medicare patients who saw Dr. Mobayed in 2024. The largest group is 75 to 84, with 182 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mobayed's median patient age at 70, with 58% women.

Medicare patients, 2024437
Average age76
Average risk score2.06
Also on Medicaid17%

Dr. Mobayed's Medicare patients by age, 2024

Dr. Mobayed's Medicare patients by sex, 2024

  • Women26360%
  • Men17440%

Chronic conditions among Dr. Mobayed's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis52%
  4. Ischemic heart disease42%
  5. Diabetes38%
  6. Chronic kidney disease35%
  7. Anxiety32%
  8. Atrial fibrillation32%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mobayed's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women58%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mohammad Mobayed wrote 808 Medicare Part D claims in 2024

In 2024, Dr. Mobayed wrote 808 Medicare Part D claims for 160 patients. 72% of them were for generic drugs. CMS names the drug for 554 of them, across 22 drugs with 11 or more claims each, at $935,025 in total drug cost. In 2023, CMS named 168 claims across 8 drugs.

Part D claims, 2024808
Drugs named by CMS22
Total drug cost$935,025
Part D patients160

Dr. Mobayed's Part D claims by kind of drug, 2024

  • Generic581 claims72%
  • Brand-name227 claims28%

Dr. Mobayed's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Mobayed's Part D claims, 2024

  • Opioids13%104 of 808 claims
  • Antibiotics3%21 of 808 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1682024: 554230%

Drugs named by CMS: 22 in 2024, 8 in 2023.

See all prescribing by Dr. Mobayed

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mohammad Mobayed scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Mobayed for performance year 2024, reported as part of a group. Dr. Mobayed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mobayed as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Mobayed by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mohammad Mobayed has 1 publication on record

Dmand AI links 1 paper to Dr. Mobayed in 2021. Dr. Mobayed's most frequent co-authors are Aditya Bardia, MD, Afshin Dowlati, MD and Shahrooz Eshaghian, MD.

Papers1

Dr. Mobayed's most frequent co-authors

Recent publications by Dr. Mobayed

See all 1 publications and co-authors

See who Dr. Mobayed researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mobayed works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mohammad Mobayed received $19,290 in industry payments from 2016 to 2025

CMS Open Payments shows 622 general payments to Dr. Mobayed from 82 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 71% of the total. US Oncology Corporate, Inc. paid the most, $3,750.

General payments to Dr. Mobayed by program year, 2016 to 2025

General payments to Dr. Mobayed by kind, 2016 to 2025

$19.3Kin total
  • Food and beverage$13,61071%
  • Consulting fees$3,08016%
  • Travel and lodging$2,14211%
  • Education$4052%
  • Gifts$530%

Companies that paid Dr. Mobayed the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mobayed

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Mohammad Mobayed's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mohammad Mobayed

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mohammad Mobayed's NPI number?

Dr. Mohammad Mobayed's NPI number is 1114134632. It was assigned on May 16, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Mohammad Mobayed?

Dr. Mohammad Mobayed is a hematologist and oncologist in Troy, Michigan. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Mohammad Mobayed practice?

Dr. Mobayed practices at 44201 Dequindre Road, Troy, MI 48085. Dr. Mobayed's primary practice is Corewell Health Beaumont Troy Hospital in Troy, Michigan, part of Corewell Health. Dmand AI also links Dr. Mobayed to 3 hospitals and 1 group practice or clinic.

What is Dr. Mohammad Mobayed's office phone number?

The practice phone on file for Dr. Mobayed is (248) 964-8800.

What is Dr. Mohammad Mobayed's medical license number?

Dr. Mobayed holds Michigan license 4301085805, one of the licenses on file in 2 states.

Which states has Dr. Mohammad Mobayed been licensed in?

Dmand AI has state licenses on file for Dr. Mobayed in Michigan and Texas.

Which hospitals is Dr. Mohammad Mobayed affiliated with?

Dr. Mobayed practices at Corewell Health Beaumont Troy Hospital in Troy, Michigan. Dr. Mobayed is also affiliated with Corewell Health William Beaumont University Hospital. Dmand AI links Dr. Mobayed to 3 more hospitals.

What medical group is Dr. Mohammad Mobayed part of?

Dr. Mobayed is linked to Oakland Macomb Cancer Specialists.

Does Dr. Mohammad Mobayed accept Medicare?

Yes. CMS data shows Dr. Mobayed billed Medicare for 26,295 services in 2024, and Dr. Mobayed accepts Medicare assignment.

Does Dr. Mohammad Mobayed offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mobayed as offering telehealth services.

Show 8 more questionsShow fewer questions

What is Dr. Mohammad Mobayed's MIPS score?

Dr. Mobayed's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.

How many Medicare patients does Dr. Mohammad Mobayed see?

CMS counts 437 Medicare patients who saw Dr. Mobayed in 2024, with an average age of 76.

What services does Dr. Mohammad Mobayed bill to Medicare?

In 2024, Dr. Mobayed's most billed Medicare services were injected or infused drug (J1453), injected or infused drug (J0897) and injected or infused drug (J1100).

What drugs does Dr. Mohammad Mobayed prescribe most?

In 2024 Medicare Part D data, Dr. Mobayed's most prescribed drugs by claims were Eliquis, Oxycodone HCl and Hydroxyurea.

Has Dr. Mohammad Mobayed received payments from drug or device companies?

CMS Open Payments shows $19,290 in general payments to Dr. Mobayed from 82 companies from 2016 to 2025. The largest total came from US Oncology Corporate, Inc.

How long has Dr. Mohammad Mobayed been practicing?

Dr. Mobayed graduated from medical school in 2004, 22 years ago.

Does Dr. Mohammad Mobayed do research?

Dmand AI links 1 publication to Dr. Mobayed.

Who does Dr. Mohammad Mobayed publish with?

Dr. Mobayed's most frequent co-authors are Aditya Bardia, MD (1 shared paper), Afshin Dowlati, MD (1 shared paper) and Shahrooz Eshaghian, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in Michigan by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)